Category: RSV
Respiratory virus activity remains ‘high’ in US and will ‘continue for several more weeks’: CDC
ABC News Respiratory viruses are continuing to spread across the United States, sickening millions of Americans. Overall respiratory illness activity — including flu, COVID-19 and RSV — continues to be listed as “high” nationwide and is causing people to seek health care “at a high level,” according to the Centers for Disease Control and Prevention. As of […]
Jan 22, 2025
‘Safety signal’ in Moderna’s RSV vaccine studies halts trials of other vaccines for childhood killer
Science Recently approved adult vaccines against respiratory syncytial virus (RSV) are already saving lives. But prospects have dimmed for some infant vaccines against the virus, which each year kills up to 100,000 children under age 5 around the world and is the leading cause of infant hospitalizations in the United States. In recent clinical trials, […]
Dec 17, 2024
Two New RSV Products to Protect Infants
Johns Hopkins A new vaccine for pregnant people and an antibody treatment for babies could substantially lower the rates of severe RSV infections among children, but rollout has been slow ahead of the first RSV season the products are available. Virtually all children get an RSV infection by the time they are 2 years old. […]
Nov 14, 2023
RSV is America’s leading cause of hospitalization for children under 5
Washington Post Each year in the United States, 2.1 million children younger than 5 receive outpatient treatment for respiratory syncytial virus (RSV), according to the Centers for Disease Control and Prevention. But for up to 80,000 youngsters, the infection becomes severe and leads to hospitalization, making RSV the country’s leading cause of infant hospitalization. In a report released […]
Oct 24, 2023
CDC alerts doctors to an increase in RSV cases among young children and babies
NBC News Cases of the respiratory illness are ticking up in Florida and Georgia, the CDC said Tuesday. The Centers for Disease Control and Prevention alerted doctors Tuesday about a rise in severe cases of RSV among young children in Florida and Georgia. Regional increases have usually predicted the beginning of RSV season nationally, the CDC wrote in its […]
Sep 5, 2023
RSV Advisory Issued by the U.S. CDC
Precision Vaccinations The Centers for Disease Control and Prevention (CDC) today announced a Health Alert Network Health Advisory CDCHAN-00498 to notify clinicians and caregivers about increased respiratory syncytial virus (RSV) activity in the Southeastern United States. Historically, such regional increases have predicted the beginning of the RSV season in the U.S. Across both prepandemic and pandemic years, RSV circulation began […]
Sep 5, 2023
GSK’s Arexvy to lead new RSV vaccines sales race with Moderna a close second: report
Fierce Pharma We waited years for working RSV vaccines and in 2023, in the space of just a few weeks, we had two come all at once, with another on the horizon and a fresh approval for an RSV prevention med. But how will the RSV market shake out? Well, the analysts at GlobalData crunched […]
Jul 25, 2023
HHS CDC Recommendation Follows the Advisory Committee on Immunization Practices’ (ACIP) Recommendations for the Use of New GSK and Pfizer RSV Vaccines for People Ages 60 Years and Older Today, in response to the Centers for Disease Control and Prevention’s (CDC) recommendation of the Respiratory Syncytial Virus (RSV) vaccine for seniors over 60, U.S. Department of […]
Jul 5, 2023
Infant RSV Vax Heads to FDA for Review
MedPageToday An FDA advisory committee on Thursday will consider whether to recommend a shot of a monoclonal antibody against respiratory syncytial virus (RSV) to prevent lower respiratory tract disease in both infants and in at-risk children up to age 2 years. The Antimicrobial Drugs Advisory Committee will examine a biologics license application approval for nirsevimab, a long-acting […]
Jun 6, 2023
The World’s First RSV Vaccine Just Got Approved in The US
Science Alert For the first time, a vaccine to protect against respiratory syncytial virus (RSV) seems poised to help thousands. The vaccine received approval on May 3 by the US Food and Drug Administration (FDA) for people over 60, and it’s a significant moment that’s been decades in the making. Should it receive approval from the US […]
May 9, 2023